U.S. dietary guidelines state that even low amounts of alcohol – less than a single drink a day – increase cancer risk.

Today, we've recommended capivasertib (also called Truqap and made by AstraZeneca) with fulvestrant as an option for around 1,100 adults with hormone receptor (HR)-positive HER2-negative breast cancer ...

A new drug that helps slow the spread of an incurable type of breast cancer has been approved for use in Britain’s state-run ...

Capivasertib is taken as a twice-daily pill, in combination with the hormone therapy fulvestrant. The drug works by blocking ...

Munich news, health insurance, technology, jobs and other topics for expatriates. The Eye Newspapers covers daily news and offers services for foreigners.

The United Kingdom’s National Institute for Health and Care Excellence (NICE) has approved a “game-changing” twice-a-day pill ...